Molecular targets of fenofibrate in the cardiovascular-renal axis: A unifying perspective of its pleiotropic benefits-Reference-Cited by-同舟云学术

Molecular targets of fenofibrate in the cardiovascular-renal axis: A unifying perspective of its pleiotropic benefits

Published:2019-06 Issue: Volume:144 Page:132-141
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Balakumar Pitchai,Sambathkumar Ramanathan,Mahadevan Nanjaian,Muhsinah Abdullatif Bin,Alsayari Abdulrhman,Venkateswaramurthy Nallasamy,Dhanaraj Sokkalingam A.

Publisher

Elsevier BV

Subject

Pharmacology

Reference95 articles.

1. Fibrates for secondary prevention of cardiovascular disease and stroke;Wang;Cochrane Database Syst. Rev.,2015

2. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction;Tenenbaum;Cardiovasc. Diabetol.,2012

3. A contemporary overview of PPARα/γ dual agonists for the management of diabetic dyslipidemia;Balakumar;Curr. Mol. Pharmacol.,2019

4. Mechanism of action of fibrates on lipid and lipoprotein metabolism;Staels;Circulation,1998

5. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice;Zhang;Clin. Sci. (Lond.),2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenofibrate reduces cardiac remodeling by mitochondrial dynamics preservation in a renovascular model of cardiac hypertrophy;European Journal of Pharmacology;2024-09

2. Regulation of pericyte metabolic reprogramming restricts the AKI to CKD transition;Metabolism;2023-08

3. From Energy Metabolic Change to Precision Therapy: a Holistic View of Energy Metabolism in Heart Failure;Journal of Cardiovascular Translational Research;2023-07-14

4. Recent Insights into the Role of PPARs in Disease;Cells;2023-06-07

5. Fenofibrate attenuates the cytotoxic effect of cisplatin on lung cancer cells by enhancing the antioxidant defense system in vitro;Oncology Letters;2023-06-06